Trials / Completed
CompletedNCT01255501
First in Human Study of NI-0701 in Healthy Volunteers
A First in Man Randomized Placebo Controlled Study of Single Ascending Intravenous Doses of NI-0701 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Light Chain Bioscience - Novimmune SA · Industry
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the safety, pharmacodynamic and pharmacokinetic profiles of a novel therapeutic drug when administered to healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NI-0701 | |
| DRUG | Placebo |
Timeline
- First posted
- 2010-12-07
- Last updated
- 2010-12-07
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01255501. Inclusion in this directory is not an endorsement.